SEC Filing: Dentsply Sirona

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Petersohn Walter

(Last)

(First)

(Middle)

221 WEST PHILADELPHIA STREET STE 60 W

(Street)

YORK

17401

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2017

3. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	44,867.9712⁽⁶⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	02/22/2027	Common Stock	18,600	62.34	D
Stock Option (Right to Buy)	⁽²⁾	03/01/2026	Common Stock	15,000	60.43	D
Stock Option (Right to Buy)	⁽³⁾	11/25/2024	Common Stock	17,748	47.41	D
Stock Option (Right to Buy)	⁽⁴⁾	11/26/2023	Common Stock	9,488	37.26	D
Stock Option (Right to Buy)	⁽⁵⁾	11/20/2022	Common Stock	7,937	34.29	D

Explanation of Responses:

1. Stock Options vest in annual one-third (1/3) increments over a three-year period ending February 22, 2020.

2. Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 1, 2019.

3. 25% vested on 11/25/2015, 25% vested on 11/25/2016, 20% shall vest on 11/25/2017, 20% shall vest on 11/25/2018 and the final 10% shall vest on 11/25/2019.

4. Stock Options vest in annual one-fourth (1/4) increments over a four-year period ending November 26, 2017.

5. This option is fully vested and exercisable.

6. Includes 34,120.9712 Restricted Stock Units (RSUs).

	Michael Friedlander, Attorney-In-Fact for Walter Petersohn	07/10/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING
OBLIGATIONS
Know all by these presents, that the undersigned
hereby constitutes and appoints each of Jonathan I.
Friedman, and Michael Friedlander, or either of them
acting singly and with full power of substitution,
the undersigned's true and lawful attorney-in-fact
to:

       1.	Execute for and on behalf of the
undersigned, in the undersigned's capacity as an
officer or director or both of DENTSPLY SIRONA Inc.
(the "Company"), Forms 3, 4 and 5 (and any amendments
thereto) in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and the rules thereunder;
       2.	To and perform any and all acts for and on
behalf of the undersigned which may be necessary or
desirable to complete and execute any such Form 3, 4
or 5, complete and execute any amendments thereto,
and timely file such form with the U.S. Securities
and Exchange Commission (the "SEC") [and any
securities exchange or similar authority], including
without limitation the filing of a Form ID or any
other documents necessary or appropriate to enable
the undersigned to file the Forms 3, 4 and 5
electronically with the SEC;
       3.	Seek or obtain, as the undersigned's
representative and on the undersigned's behalf,
information on transactions in the Company's
securities from any third party, including brokers,
employee benefit plan administrators and trustees,
and the undersigned hereby authorizes any such person
to release any such information to each of the
undersigned's attorneys-in-fact appointed by this
Limited Power of Attorney and approves and ratifies
any such release of information;
       4.	Take any other action in connection with the
foregoing which, in the opinion of such attorney-in-
fact, may be of benefit to, in the best interest of,
or legally required by or for, the undersigned, it
being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned
pursuant to this Limited Power of Attorney shall be
in such form and shall contain such information and
disclosure as such attorney-in-fact may approve in
such attorney-in-fact's discretion.
	The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever
required, necessary or proper to be done in the
exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present,
with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-
fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by
virtue of this Limited Power of Attorney and the
rights and powers herein granted.
           The undersigned acknowledges that the
foregoing attorney(s)-in-fact, in serving in such
capacity at the request and on the behalf of the
undersigned, is(are) not assuming, nor is the Company
assuming, any of the undersigned's responsibilities
to comply with, or any liability for the failure to
comply with, any provision of Section 16 of the
Exchange Act.
           This Limited Power of Attorney shall remain
in full force and effect until the undersigned is no
longer required to file Forms 3, 4 or 5 with respect
to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing
delivered to the foregoing attorney(s)-in-fact.
IN WITNESS WHEREOF, the undersigned has executed this
Limited Power of Attorney as of this 1st, day of July,
2017.


Signed and acknowledged:


__/s/________________________________________
Signature


__Walter Petersohn______________________
Printed Name

 the undersigned has executed this
Limited Power of Attorney as of this 1st, day of July,
2017.


Signed and acknowledged: